Cargando…

Hospitalisation among vaccine breakthrough COVID-19 infections

Detalles Bibliográficos
Autores principales:	Juthani, Prerak V, Gupta, Akash, Borges, Kelly A, Price, Christina C, Lee, Alfred I, Won, Christine H, Chun, Hyung J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423430/ https://www.ncbi.nlm.nih.gov/pubmed/34506735 http://dx.doi.org/10.1016/S1473-3099(21)00558-2

Ejemplares similares

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
por: Wang, Stephen Y, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis
por: Madeeva, Daria V, et al.
Publicado: (2021)

Omicron breakthrough infections in patients with immune-mediated inflammatory diseases
por: Liew, Jean W, et al.
Publicado: (2022)

Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes
por: Leshem, Eyal, et al.
Publicado: (2021)

Vaccination prevents hospitalisations of children and adolescents. A real-world analysis
por: Bolcatto, Pablo G.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City
por: Saxena, Amit, et al.
Publicado: (2022)

The incidence of Coronavirus disease 2019 (COVID-19) among vaccinated healthcare workers (HCWs): evidence for protection from hospitalisation from an Indonesian cohort
por: Kozlakidis, Zisis
Publicado: (2023)

Monoclonals for patients hospitalised with COVID-19
por: Pogue, Jason M, et al.
Publicado: (2022)

Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England
por: Møller Kirsebom, Freja Cordelia, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period
por: Boekel, Laura, et al.
Publicado: (2022)

COVID-19 and involuntary hospitalisation: navigating the challenge
por: Gold, Azgad, et al.
Publicado: (2020)

Convalescent plasma in patients hospitalised with COVID-19
por: Liu, Sean T H, et al.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19) Manifestation as Acute Myocardial Infarction in a Young, Healthy Male
por: Juthani, Prerak, et al.
Publicado: (2020)

Antiviral monotherapy for hospitalised patients with COVID-19 is not enough
por: Cao, Bin, et al.
Publicado: (2020)

Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties
por: Matthay, Michael A, et al.
Publicado: (2020)

Baricitinib as the treatment of choice for hospitalised individuals with COVID-19
por: Richardson, Peter J., et al.
Publicado: (2022)

Fixed cell-based assays for autoantibody detection in myasthenia gravis: a diagnostic breakthrough
por: Budhram, Adrian
Publicado: (2023)

COVID-19 outbreak and decreased hospitalisation of pregnant women in labour
por: Kumari, Vimla, et al.
Publicado: (2020)

Renin-angiotensin system inhibitors in hospitalised patients with COVID-19
por: Williams, Bryan
Publicado: (2021)

Early oral antiviral use in patients hospitalised with COVID-19
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Alternatives to conventional hospitalisation that enhance health systems' capacity to treat COVID-19
por: Nicolás, David, et al.
Publicado: (2021)

Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19
por: Shapiro, Adrienne E, et al.
Publicado: (2022)

High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19
por: So-Osman, Cynthia, et al.
Publicado: (2022)

Cerebral venous sinus thrombosis after vaccination: the UK experience
por: Lee, Eun-Ju, et al.
Publicado: (2021)

SARS-CoV-2 spread and hospitalisations in paediatric patients during the omicron surge
por: Belay, Ermias D, et al.
Publicado: (2022)

Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June–July, 2021
por: Shah, Syed Ahmar, et al.
Publicado: (2021)

Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants
por: Kislaya, Irina, et al.
Publicado: (2022)

Population immunity and vaccine protection against infection
por: Leshem, Eyal, et al.
Publicado: (2021)

Rethinking vaccine hesitancy among minority groups
por: Khan, Mishal S, et al.
Publicado: (2021)

Addressing vaccine inequities among Ukrainian refugees
por: Hill, Matilda, et al.
Publicado: (2022)

B cells: more than just for antibodies in SARS-CoV-2 vaccine responses
por: Paley, Michael A, et al.
Publicado: (2021)

Optimism and caution for an inactivated COVID-19 vaccine
por: Rostad, Christina A, et al.
Publicado: (2021)

The antibody response of haematological malignancies to COVID-19 infection and vaccination
por: Seebacher, Nicole A.
Publicado: (2022)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

Convalescent plasma from people vaccinated after COVID-19 infection
por: Jabal, Kamal Abu, et al.
Publicado: (2021)

Interplay of infection and vaccination in long-term protection from COVID-19
por: Tan, Hyon-Xhi, et al.
Publicado: (2022)

Assortative mixing among vaccination groups and biased estimation of reproduction numbers
por: Klaus, Colin, et al.
Publicado: (2022)

Barriers to COVID-19 vaccination among older adults in Mexico City
por: Gaitán-Rossi, Pablo, et al.
Publicado: (2022)

Safety of mRNA COVID-19 vaccines during pregnancy
por: Ellington, Sascha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d7i9ih59ddlrq5grcgot8vml28